Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-Dose Phase 1 Clinical Trial to Evaluate Safety, Tolerability and Pharmacokinetics of RHN-001 in Healthy Adult Volunteers.

NCT05847218 is registered in ClinicalTrials.gov with RH Nanopharmaceuticals as lead sponsor.

NCT NCT05847218
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05847218 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-Dose Phase 1 Clinical Trial to Evaluate Safety, Tolerability and Pharmacokinetics of RHN-001 in Healthy Adult Volunteers.
Lead sponsor
RH Nanopharmaceuticals
Phase
Phase 1
Overall status
Completed
Start date
March 9, 2023
Completion date
March 19, 2023
Enrollment
64 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pharmacokinetics, safety, tolerability